| Product NDC: | 16590-514 |
| Proprietary Name: | PAXIL |
| Non Proprietary Name: | PAROXETINE HYDROCHLORIDE |
| Active Ingredient(s): | 12.5 mg/1 & nbsp; PAROXETINE HYDROCHLORIDE |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, FILM COATED, EXTENDED RELEASE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 16590-514 |
| Labeler Name: | STAT RX USA LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020936 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20020409 |
| Package NDC: | 16590-514-30 |
| Package Description: | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (16590-514-30) |
| NDC Code | 16590-514-30 |
| Proprietary Name | PAXIL |
| Package Description | 30 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (16590-514-30) |
| Product NDC | 16590-514 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | PAROXETINE HYDROCHLORIDE |
| Dosage Form Name | TABLET, FILM COATED, EXTENDED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20020409 |
| Marketing Category Name | NDA |
| Labeler Name | STAT RX USA LLC |
| Substance Name | PAROXETINE HYDROCHLORIDE |
| Strength Number | 12.5 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |